Get Care Now
Carson Tahoe Health
At Carson Tahoe Health, we are committed to advancing care through innovation, compassion, and evidence-based practices. This is especially important when it comes to mental health.
A growing area of research gaining national attention is psychedelic-assisted therapy. Leading institutions, including Johns Hopkins University, have helped bring this work into the spotlight. In fact, researchers from Johns Hopkins have created educational resources that explore both the science and potential of these treatments, including this video overview:
https://www.youtube.com/watch?v=25g-1qpVkSE
This evolving field is something Dr. Tabaac has been closely following. He contributes through education, awareness, and ongoing dialogue.
Understanding Psychedelic-Assisted Therapy
Psychedelic-assisted therapy involves the supervised use of compounds such as psilocybin. It is combined with structured psychotherapy. These therapies take place in controlled clinical environments. They emphasize safety, preparation, and guided integration.
A recent peer-reviewed overview published in American Therapeutics provides a helpful primer for clinicians and patients alike, outlining both the clinical considerations and emerging evidence:
https://journals.lww.com/americantherapeutics/fulltext/2024/04000/psychedelic_therapy__a_primer_for_primary_care.4.aspx
Research continues to explore its potential in treating:
- Treatment-resistant depression
- Post-traumatic stress disorder (PTSD)
- Anxiety, especially related to serious illness
Dr. Tabaac’s Perspective and Work
Dr. Tabaac has been an advocate for expanding conversations around mental health treatment—especially for patients who may not respond to traditional therapies.
Through speaking engagements, interviews, and educational platforms, he has helped bring awareness to the potential role of psychedelic-assisted therapy in modern medicine. In his recent TEDx talk, Dr. Tabaac discusses the evolving landscape of mental health care and the importance of reducing stigma:
https://www.youtube.com/watch?v=yk-vcGyXaCA&t=43s
He also shares additional insights in a recent interview, where he discusses both the science and the future of these therapies:
https://www.youtube.com/watch?v=qVoqGUMpN7E&t=1039s
As he often emphasizes, this is not about replacing existing care, but about expanding the toolkit available to providers and patients alike.
“We are entering a time where mental health care is evolving. Our responsibility is to approach new treatments with both curiosity and caution—grounded in science and centered on the patient.”
Why This Matters Now
Mental health challenges continue to rise across the country, and many individuals struggle to find effective, lasting relief. While traditional therapies remain essential, there is increasing recognition that new approaches may be needed to meet the complexity of these conditions. Educational resources, like those developed by Johns Hopkins University, along with ongoing clinical research and physician-led advocacy, are helping shape a more informed and balanced understanding of these therapies.
A Thoughtful Path Forward
At Carson Tahoe Health, our priority is always safe, high-quality, patient-centered care. While psychedelic-assisted therapy is still an emerging area and subject to evolving regulatory guidance, we remain committed to:
- Staying informed on the latest research
- Supporting provider education and community awareness
- Exploring innovative approaches that align with clinical best practices
Dr. Tabaac’s engagement in this space reflects a broader commitment to advancing mental health care in a responsible and meaningful way.
Looking Ahead
As research continues and conversations evolve, we will continue to share updates and insights with our community. The future of mental health care is being shaped today and through thoughtful exploration, collaboration, and innovation, we can continue to improve the lives of those we serve.
Carson Tahoe Health
